Speckle Contrast as Retinal Tissue Integrity Biomarker in Patients with Type 1 Diabetes Mellitus with No Retinopathy.
Elvira Orduna-HospitalMaria Arcas-CarbonellAna I Sánchez-CanoIsabel PinillaAlejandra ConsejoPublished in: Journal of personalized medicine (2022)
Statistically significant differences were found in speckle contrast and thickness between the control and the DM1 group, suggesting an IRL alteration of DM1 patients, supporting the retinal neurodegeneration before DR signs are observed.
Keyphrases
- optical coherence tomography
- end stage renal disease
- diabetic retinopathy
- magnetic resonance
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- type diabetes
- contrast enhanced
- magnetic resonance imaging
- computed tomography
- glycemic control
- metabolic syndrome
- adipose tissue
- insulin resistance